Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC
出版年份 2016 全文链接
标题
Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGY
Volume 232, Issue 1, Pages 71-83
出版商
Bioscientifica
发表日期
2016-11-01
DOI
10.1530/joe-16-0322
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of sodium butyrate supplementation on reproductive performance and colostrum composition in gilts
- (2016) B. He et al. Animal
- Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice
- (2016) Haixiao Li et al. BRAIN RESEARCH
- Involvement of 15-lipoxygenase-1 in the regulation of breast cancer cell death induced by sodium butyrate
- (2016) Vahid Salimi et al. CYTOTECHNOLOGY
- C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21
- (2016) Hao Wu et al. DIABETOLOGIA
- Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice
- (2016) Umadevi Subramanian et al. PHYSIOLOGICAL GENOMICS
- Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2
- (2015) Hao Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion
- (2015) Hui Liu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Metallothionein deletion exacerbates intermittent hypoxia-induced renal injury in mice
- (2015) Hao Wu et al. TOXICOLOGY LETTERS
- Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
- (2014) E. T. Hall et al. DIABETES
- Noninvasive In Vivo Imaging of Diabetes-Induced Renal Oxidative Stress and Response to Therapy Using Hyperpolarized13C Dehydroascorbate Magnetic Resonance
- (2014) Kayvan R. Keshari et al. DIABETES
- Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats
- (2014) Sabbir Khan et al. FOOD AND CHEMICAL TOXICOLOGY
- Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats
- (2013) A. Nihal Sari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
- (2013) Lukasz Krokowicz et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?
- (2013) Toshio Miyata et al. KIDNEY INTERNATIONAL
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- AMPK synergizes with the combined treatment of 1′-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities
- (2013) Keisuke Yaku et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Curcumin-From Molecule to Biological Function
- (2012) Tuba Esatbeyoglu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
- (2012) Rubhana Raqib et al. BMC INFECTIOUS DISEASES
- Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome
- (2012) T. Banasiewicz et al. Colorectal Disease
- Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
- (2012) M.-Z. Zhang et al. DIABETES
- The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53
- (2012) Keisuke Yaku et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway
- (2012) Vivian Soetikno et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modification of Keap1 Cysteine Residues by Sulforaphane
- (2011) Chenqi Hu et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy: FIG. 1.
- (2011) Judy B. de Haan DIABETES
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: Identification of functional antioxidant response elements on the Nox4 promoter
- (2011) Srikanth Pendyala et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells
- (2011) Matthew J. Kesic et al. FREE RADICAL BIOLOGY AND MEDICINE
- Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
- (2009) Z. Gao et al. DIABETES
- Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
- (2008) Xiaoqing He et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The pathogenesis of diabetic nephropathy
- (2008) Suma Dronavalli et al. Nature clinical practice. Endocrinology & metabolism
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started